Stockreport

Avadel Pharma's Noctiva shows positive effect in late-stage nocturia study; shares up 1% [Seeking Alpha]

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com
PDF Updated data from a Phase 3 clinical trial evaluating Avadel Pharmaceuticals' ( AVDL ) NOCTIVA (desmopressin acetate) Nasal Spray for the treatment of nocturia [Read more]